Tyrosine sulfation: a modulator of extracellular protein–protein interactions  by Kehoe, John W & Bertozzi, Carolyn R
Minireview R57
Tyrosine sulfation is a post-translational modification of
many secreted and membrane-bound proteins. Its
biological roles have been unclear. Recent work has
implicated tyrosine sulfate as a determinant of
protein–protein interactions involved in leukocyte
adhesion, hemostasis and chemokine signaling.
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The study of living systems has been transformed by an
explosion of genetic information. It is clear, however,
that the structure of a mature protein is not dependent
solely upon its gene. Post-translational modifications,
such as glycosylation, proteolysis, phosphorylation, acyla-
tion, adenylation, farnesylation, ubiquitination, and sul-
fation, abound in living systems. These modifications
affect a wide range of protein behaviors and characteris-
tics, including enzyme activity, protein lifespan and
protein–protein interactions.
Protein tyrosine sulfation is emerging as a widespread
post-translational modification in multicellular eukaryotes.
To our knowledge, protein tyrosine sulfation was first
observed over four decades ago, in a peptide derived from
fibrinogen [1]. In the mid-1980s, a series of tyrosine-sul-
fated proteins was discovered, which includes diverse
molecules such as α-choriogonadotrophin and heparin
cofactor II (a list of human proteins known to be tyrosine
sulfated is shown in Table 1) [2]. Many of these tyrosine-
sulfated proteins participate in protein–protein interac-
tions that seem to be driven, at least in part, by
recognition of the sulfate group itself. In the past few
years, tyrosine sulfation has been identified as a key mod-
ulator of protein–protein interactions that mediate inflam-
matory leukocyte adhesion. The recent discovery of
tyrosine-sulfated chemokine receptors suggests an even
broader role in the inflammatory response.
Biological roles of tyrosine sulfation in the vasculature
At sites of inflammation, leukocytes roll on, adhere to, and
transmigrate between the endothelial cells lining blood
vessel walls (Figure 1a). Rolling is the requisite initial
adhesion event in leukocyte recruitment to sites of inflam-
mation. It is mediated in some sites by the interaction of
P-selectin on activated endothelial cells with the
P-selectin glycoprotein ligand (PSGL)-1 on cognate
leukocytes [3]. PSGL-1 was identified at the molecular
level in 1993, using expression cloning [4]. Glycosylation
of PSGL-1 was known to be a major determinant of
P-selectin binding, but was not sufficient to explain the
binding avidities observed in vivo. 
Further investigations revealed that tyrosine sulfation near
the amino terminus of PSGL-1 plays an essential role in
P-selectin binding (shown schematically in Figure 1b).
Three papers published within one month of each other in
1995 provided the first evidence of this phenomenon
[5–7]. Progressive deletions of the PSGL-1 amino termi-
nus by Pouyani and Seed [5] revealed that a 20-residue
peptide was required for high-affinity binding. Further-
more, mutagenesis within this sequence showed that the
three tyrosine residues carried sulfate and were required
for binding to P-selectin. Similar results were obtained by
Sako et al. [6]. In a third report, Wilkins et al. [7] found that
treating PSGL-1 with bacterial arylsulfatase reduced
P-selectin binding activity. More recent work determined
that proteolytic cleavage of the amino-terminal ten
residues from mature PSGL-1 eliminated P-selectin
binding [8]. Notably, this information was used to design a
simple glycosulfopeptide that binds P-selectin with high
affinity and inhibits its interaction with neutrophils [9].
Tyrosine sulfation is also involved in hemostasis. When
blood vessels are injured, the subendothelial matrix is
exposed to blood flow. The body responds by forming a
thrombus, or platelet aggregate, at the site of injury. The
complete mechanism of platelet attachment is an area of
active research, but von Willebrand factor (vWF) and the
platelet membrane protein GP Ibα are known to be
involved in the early steps of adhesion [10,11]. vWF is a
plasma protein that bridges subendothelial collagen and
platelet GP Ibα, thereby mediating the initial interactions
between platelets and the subendothelium. Platelet
binding to vWF is partially dependent upon the sulfation
of three tyrosine residues within GP Ibα [12]. Proteolytic
removal of the tyrosine-sulfated segment reduced binding
potency by an order of magnitude [13,14].
Tyrosine sulfation of chemokine receptors
Last year, the importance of tyrosine sulfation suddenly
increased once again, with the first report of a tyrosine-sul-
fated chemokine receptor. Chemokines are small, secreted
proteins that are involved in leukocyte trafficking, angio-
genesis, angiostasis, battling viral infections, and the host
immune response to cancer [15]. These proteins exert their
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effects through G-protein-coupled receptors on target cells.
Farzan et al. [16] showed that the chemokine receptors
CCR5 and CXCR4 are tyrosine sulfated. CCR5 carries four
tyrosine residues in the amino-terminal region, all of which
show some degree of sulfation in cell culture. Incubation of
CCR5-expressing Cf2Th cells with sodium chlorate, a
global inhibitor of sulfation, decreased binding of MIP-1α
and MIP-1β—two natural chemokine ligands for CCR5
[16]. Sulfotyrosine 14 of CCR5 seems to play a particularly
important role in binding to the chemokines MIP-1α and
RANTES (M. Farzan, personal communication). 
In addition to binding native chemokines, CCR5 also
serves as a co-receptor for HIV gp120, working together
with CD4 to mediate attachment of the virus and its sub-
sequent invasion [17,18]. Mutation of the four sulfotyro-
sine residues in CCR5 to phenylalanine inhibits HIV
infection by 50–75% in cultured cells, depending on the
HIV isolate tested [16]. This information suggests that
inhibitors of tyrosine sulfation might serve as anti-HIV
therapeutics, as long as disruption of the modification is
not globally toxic. Alternatively, peptides that mimic the
tyrosine-sulfated sequence of CCR5 might compete for
binding to HIV gp120 and block viral adhesion.
Prediction of tyrosine sulfation
The prevalence of tyrosine sulfation across the proteome
is still unknown. The enzymes that generate the modifica-
tion, tyrosyl protein sulfotransferases (TPSTs, described
below), reside in the Golgi compartments and therefore
have access to secreted and membrane-bound proteins.
One might hope to find a consensus sequence for tyrosine
sulfation amongst these proteins that would be of predic-
tive value. Examination of the local sequences at known
sites of tyrosine sulfation reveals a preponderance of acidic
residues, but no defined consensus is evident (Table 1).
Still, the common features of tyrosine sulfation sites have
been identified in numerous chemokine receptors, as well
as other seven-transmembrane segment (7TMS) recep-
tors. The sequences listed in Table 2 have been shown to
acquire tyrosine sulfate when expressed as fusions with a
carrier protein. These modifications, if they exist on the
native 7TMS receptors, may contribute to ligand binding
affinity and/or specificity. 
Tyrosyl protein sulfotransferases
A major advance in the field came with the molecular
cloning of two tyrosyl protein sulfotransferases, TPST-1
and TPST-2, from human and mouse in 1998 [19–21].
Both are membrane-bound, N-glycosylated Golgi enzymes
with a lumenal catalytic domain, a single-span transmem-
brane domain, and a short cytosolic tail. The human
TPSTs share 67% sequence identity. Caenorhabditis elegans
was found to have a related protein, called TPST-A, that is
54% identical to human TPST-1 [20]. A second C. elegans
gene, whose function is unknown, has 39% identity and
62% similarity to TPST-A. Northern analysis indicates
that both human TPSTs are expressed in many tissues. It
has not been determined, however, whether the two
TPSTs are co-expressed in the same cells. It is possible
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Table 1
Human proteins known to be tyrosine sulfated.
Protein Sulfation site(s), if known Reference
Amyloid precursor [36]
α-2-Antiplasmin PPMEEDYPQFGSP [37]
CCR5 H2N-MDYQVSSPIYDINYYTSEPCQ [16]
Cholecystokinin RISDRDYMGWMDF [38]
α-Choriogonadotropin CHCSTCYYHKS-COOH [39]
Coagulation factor V [40]
Coagulation factor VIII NEEAEDYDDDLTD [41]
DKNTGDYYEDSYEDS
DQEEIDYDDTISV
KEDFDIYDEDEN
Complement C4 MEANEDYEDYEYDELPAK [42]
Dermatan sulfateproteogylcan [43]
α-Fetoprotein [44]
Fibrin [45]
Fibronectin [44]
Gastrin EEEEEAYGWMDF [46]
Glycoprotein Ib-α EGDTDLYDYYPEEDTE [12]
Heparin cofactor II GEEDDDYLDLEKIFSEDDDYIDIVDS [47]
PSGL-1 H2N-QATEYEYLDYDFLPET [5]
Procollagen type II [48]
S-protein [49]
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that additional TPSTs have not yet been discovered. The
existence of more than one TPST might explain the diver-
sity of sequences that are tyrosine sulfated; each enzyme
might have a different substrate specificity and act upon a
different subset of target proteins.
Like all sulfotransferases, the TPSTs use 3′-phospho-
adenosine 5′-phosphosulfate (PAPS) as a sulfate donor
(Figure 2). Mammals, yeast and Escherichia coli can all
produce PAPS through a similar pathway ([22] and refer-
ences therein). ATP and inorganic sulfate are first con-
verted to adenosine 5′-phosphosulfate (APS) by the action
of ATP sulfurylase. APS kinase then phosphorylates APS
to produce PAPS. In mammals, the sulfurylase activity
and the kinase activity both reside within the same
polypeptide chain [23]. Finally, PAPS is imported into the
Golgi compartments by a specific transporter [24,25]. The
existence of PAPS in an organism or cell does not
mandate the presence of tyrosine sulfation. To our knowl-
edge, there are no instances of tyrosine sulfation in yeast
or prokaryotes. 
Structural aspects of sulfotransferases
Although no structural data exists for the TPSTs, insights
can be drawn from sequence comparisons with other
sulfotransferases of known structure. Two cytosolic sulfo-
transferases have been crystallized: estrogen sulfotrans-
ferase (EST) [26] and the catecholamine sulfotransferase
SULT1A3 [27,28]. The structure of the sulfotransferase
domain of heparan sulfate N-deacetylase/N-sulfotrans-
ferase 1, a Golgi-localized enzyme, has also been reported
[29]. These three structures all revealed a PAPS binding
motif—the ‘PSB loop’— which has the sequence
K(S/T)GTT. This motif is found in a wide range of sulfo-
transferases [30], and it is also found in the TPSTs. In a
co-crystal structure with mouse EST, 3′,5′-diphospho-
adenosine (3′5′-ADP) interacts with the PSB loop through
hydrogen bonding with amide protons of the peptide
backbone and sidechain atoms from lysine and threonine
residues [26]. The TPSTs might have similar interactions;
future mutagenesis and crystallographic studies will be
required to address this.
Structural and mechanistic studies of cytosolic and carbo-
hydrate sulfotransferases suggest that these enzymes share
some features with kinases. The fold of EST most resem-
bles that of the uridylate, adenylate and guanylate kinases
[26]. Co-crystal structures of EST bound to vanadate indi-
cate that the active site is designed for an in-line attack on
sulfate by a hydroxyl group of the substrate estradiol [31].
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Figure 1
Tyrosine sulfation plays an important role in the immune response.
(a) Leukocytes roll upon, adhere to and transmigrate between
endothelial cells at sites of inflammation. P-selectin and its ligand,
PSGL-1, are often required for this process. (b) PSGL-1 is a mucin-
like glycoprotein that appears to be an extended rod shape in vivo
[50]. The extreme amino terminus of PSGL-1 carries three tyrosine
sulfation sites, shown in yellow. These sulfate esters, and specific
glycans on PSGL-1, are key binding determinants for P-selectin. See
Table 1 for the sequence of the sulfation site.
Table 2
Some 7TMS receptors with possible sulfation sites [16].
Receptor Presumed tyrosine sulfation site
CCR2b VTTFFDYDYGAPCHK
CCR3 TFGTTSYYDDVGLLCE
CCR8 H2N-MDYTLDLSVTTVTDYYYPDIFSSPC
d6 AENSSFYYYDYLDEVAF
CXCR3 ENFSSSYDYGENESD
CXCR4 H2N-MEGISIYTSDNYTEEMGSGDYDSMKEP
str133 H2N-MAEHDYHEDYGFSSFN
dez H2N-MRMEDEDYNTSISYGDEYPDYLDSIVV
gpr1 TLFEEFENYSYDLDYYSLESDL
gpr15 EETSVYLDYYYATSPNS
apj GGDFDNYYGADNQSECEYTDW
c5aR H2N-MNSFNYTTPDYGHYDD
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The catalytic domain of heparan sulfate reveals a similar
design [29]. The reactions catalyzed by kinases are also
thought to proceed via an in-line direct transfer mecha-
nism [32]. The relationship of TPSTs to kinases with
respect to structure and mechanism should be addressed
in crystallographic and mechanistic studies.
Regulation of tyrosine sulfation
How dynamic is tyrosine sulfation? Many signaling path-
ways are known to depend upon the phosphorylation state
of various tyrosine residues. Living systems produce both
kinases and phosphatases to adjust phosphorylation
rapidly in response to signals. So far as we know, there is
no comparable dynamic regulation of tyrosine sulfation.
The TPSTs appear to be constitutively active, and the
location of tyrosine sulfated proteins — secreted or
exposed on the extracellular face of the plasma membrane
— might preclude the rapid removal of sulfate from a par-
ticular target protein. Both prokaryotic and eukaryotic
arylsulfatases exist, but we are not aware of any whose
primary physiological role is the removal of sulfate from
tyrosine. The human arylsulfatases A and B are, however,
known to accept a range of artificial sulfated substrates
that carry a phenolic ring [33]. These sulfatases reside in
the lysosome and might participate in degradation of a
broad spectrum of tyrosine-sulfated proteins [34]. In con-
trast, arylsulfatase E is found in the Golgi compartment
[35]. A possible regulatory role for this enzyme has not yet
been addressed.
Future directions
The functional significance of tyrosine sulfation, as
revealed by studies of PSGL-1 and chemokine receptors,
underscores the importance of the many still-unanswered
questions. One of the most fundamental of these questions
is: which proteins normally carry tyrosine sulfate in vivo?
The identification of the full complement of tyrosine-sul-
fated proteins would allow a better understanding of the
roles tyrosine sulfate plays in living systems. At present
there is no simple way to accomplish this. We suspect that
generating an anti-tyrosine sulfate antibody using conven-
tional methods would be difficult because tyrosine sulfate
is found on numerous secreted and membrane-bound pro-
teins. The purpose of multiple TPSTs is also unclear. This
situation could benefit greatly from the tools of chemical
biology. For example, cell-permeable small-molecule
inhibitors that are specific for each TPST could be used to
deconvolute their substrates. Coupling TPST inhibition
with functional assays of protein–protein binding could
uncover hitherto unknown roles for tyrosine sulfation.
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